Endocrinology and Diabetes

Welcome Message

Welcome to the 3rd International Congress on Endocrinology and Diabetes, scheduled to be held on December 03–04, 2026, in the historic city of Rome, Italy, under the theme Innovations in Endocrinology and Diabetes Management. This international congress invites endocrinologists, diabetologists, physicians, researchers, healthcare professionals, academicians, industry experts, policymakers, and students from around the world to share knowledge and discuss recent advancements in endocrinology, diabetes, and metabolic health. It provides a global platform for scientific exchange, collaboration, and the presentation of innovative research.

Participants will have the opportunity to engage with leading experts, present their research findings, and explore current developments and challenges in endocrine and metabolic healthcare. Through keynote lectures, scientific sessions, poster presentations, and networking opportunities, the congress is designed to promote interdisciplinary collaboration and encourage the translation of research into improved clinical practice and patient care.

We look forward to welcoming you to Rome for a productive and enriching scientific experience.

About Conference

The 3^rd International Congress on Endocrinology and Diabetes (Endocrine Congress 2026) will be held on December 03–04, 2026, in Rome, Italy, focusing on the theme Innovations in Endocrinology and Diabetes Management. This international congress brings together clinicians, researchers, healthcare professionals, academicians, industry experts, and students to discuss recent advances in endocrinology, diabetes, and metabolic health. It provides a global platform to share knowledge, present research findings, and encourage collaboration across all areas of endocrine science.

The Endocrine Congress 2026 scientific program will include keynote lectures, plenary sessions, oral and poster presentations, panel discussions, and interactive scientific sessions delivered by leading experts in the field. It is designed to present cutting-edge research, clinical experiences, and emerging innovations in endocrinology and diabetes.

The congress is designed to promote scientific exchange, interdisciplinary collaboration, and professional networking among participants from around the world. All registered delegates, speakers, and presenters will receive a Certificate of Participation, while selected contributions will be recognized through special scientific awards for excellence in research and presentations.

The Endocrine Congress 2026 will be conducted in both onsite and virtual formats, enabling global participation and allowing delegates to join from any location.

Why to Attend

Attend the 3rd International Congress on Endocrinology and Diabetes to gain insights into the latest research, innovations, and clinical advancements in endocrine and metabolic health. Connect with leading experts, researchers, healthcare professionals, and industry leaders from around the world. Discover emerging technologies, evidence-based practices, and novel therapeutic approaches through interactive sessions and discussions. The congress offers valuable opportunities for networking, collaboration, professional development, and knowledge exchange, helping participants stay at the forefront of endocrinology and diabetes care.

Key Features

• Keynote and Plenary Sessions
• Oral Scientific Presentations
• Poster Presentation Sessions
• Young Researchers Forum
• Interactive Panel Discussions
• Industry and Technology Exhibition
• Networking Opportunities with Global Experts
• Updates in Diabetes and Metabolic Health
• Advances in Endocrinology Research and Innovation
• Digital Health and Artificial Intelligence Applications
• Publication Opportunities in Indexed Journals
• Certificate of Participation for All Registered Delegates

Target Audience

• Endocrinologists
• Diabetologists
• Internal Medicine Physicians
• Clinical Researchers and Scientists
• Healthcare Professionals and Practitioners
• Metabolism and Obesity Specialists
• Paediatric Endocrinologists
• Reproductive Endocrinologists
• Endocrine Surgeons
• Nurses and Diabetes Educators
• Nutritionists and Dietitians
• Pharmacists and Clinical Pharmacologists
• Academic Faculty and Educators
• Medical and Graduate Students
• General Physicians and Family Medicine Practitioners
• Cardiologists with interest in cardiometabolic health
• Public Health Professionals and Epidemiologists
• Geneticists and Molecular Biologists
• Clinical Trial Researchers and Data Scientists
• Hospital Administrators and Healthcare Policy Makers

Abstract Submission and Registration Guidelines

The 3^rd International Congress on Endocrinology and Diabetes welcomes endocrinologists, diabetologists, researchers, clinicians, healthcare professionals, academicians, industry experts, and students to submit their original research and scientific contributions. Participants are invited to submit abstracts, full papers, case reports, posters, and e-poster presentations related to endocrinology, diabetes, metabolic disorders, obesity, thyroid diseases, reproductive endocrinology, paediatric endocrinology, endocrine oncology, and allied healthcare disciplines.

Submission Guidelines

• Abstracts should not exceed 500 words.
• The title must be written in sentence case.
• Complete author details, including full names and institutional affiliations, must be provided.
• A brief biography of the presenting author (maximum 150 words) and a recent passport-size photograph should be submitted.

Review Process

All submissions will undergo peer review by the Conference Scientific Committee. Authors will receive acceptance notifications, revision requests, or feedback via email following the review process.

Publication Opportunity

Accepted abstracts and papers will be published in the official conference proceedings and associated international journals, providing authors with global visibility and academic recognition.

Abstract Submission Link: https://endocrinology.global-summit.com/abstract-submission.php

How to Register

Visit the conference registration page to explore registration categories, participation options, and secure your place at the congress. Join leading researchers, clinicians, and healthcare professionals from around the world in advancing endocrinology and diabetes care.

Registration Link: https://endocrinology.global-summit.com/registration.php

Sessions and Tracks

Track 1: Endocrinology

Endocrinology focuses on the study of hormones, endocrine glands, and their vital role in regulating growth, metabolism, reproduction, and overall health. This track highlights recent advances in endocrine research, diagnostic approaches, hormonal disorders, and precision medicine. It provides a platform for researchers and clinicians to discuss innovative discoveries, clinical challenges, and emerging technologies that improve endocrine care and patient outcomes.

• Thyroid and Parathyroid Disorders
• Pituitary and Adrenal Gland Diseases
• Reproductive and Paediatric Endocrinology
• Hormonal Regulation, Metabolism, and Endocrine Research

Track 2: Diabetes Mellitus and Glycaemic Control

Diabetes Mellitus and Glycaemic Control focuses on the epidemiology, pathophysiology, diagnosis, and comprehensive management of diabetes mellitus. The program covers Type 1, Type 2, and gestational diabetes, emphasising early detection, individualised treatment approaches, and advances in glucose-monitoring technologies and insulin therapies. Discussions will also highlight innovative strategies to prevent complications, optimise glycaemic control, and improve long-term patient outcomes and quality of life.

Types of diabetes:

• Type 1 Diabetes
• Type 2 Diabetes
• Gestational Diabetes
• Glycaemic Monitoring Technologies

Track 3: Thyroid Disorders

Thyroid Disorders addresses the diagnosis, evaluation, and management of hypothyroidism, hyperthyroidism, autoimmune thyroid diseases, and thyroid cancer. Participants will explore advances in diagnostic imaging, laboratory testing, molecular diagnostics, and personalised treatment approaches. Scientific discussions will also examine current clinical guidelines, innovative therapies, and future research aimed at enhancing patient care and improving long-term thyroid health outcomes.

Types of thyroid disorders includes:

• Hypothyroidism
• Hyperthyroidism
• Autoimmune Thyroid Disorders
• Thyroid Cancer

Track 4: Public Health and Global Endocrine Challenges

Public Health and Global Endocrine Challenges examines the growing burden of endocrine and metabolic diseases across diverse populations. Scientific discussions will address epidemiology, health disparities, disease prevention, public health policies, and global healthcare initiatives. Participants will explore strategies to improve healthcare accessibility, strengthen health systems, and promote  equitable endocrine care through international collaboration and evidence-based public health interventions.

• Epidemiology
• Health Policy
• Disease Prevention
• Global Health Initiatives

Track 5: Paediatric Endocrinology

Paediatric Endocrinology focuses on endocrine disorders affecting infants, children, and adolescents, including growth disorders, childhood diabetes, congenital endocrine diseases, and puberty-related conditions. Experts will discuss advances in early diagnosis, treatment strategies, transitional care, and long-term disease management. Emphasis will be placed on improving health outcomes, quality of life, and comprehensive endocrine care for young patients.

• Growth Disorders
• Paediatric Diabetes
• Pubertal Disorders
• Congenital Endocrine Diseases

Track 6: Obesity and Metabolic Syndrome

Obesity and Metabolic Syndrome explores the biological, environmental, genetic, and behavioural factors contributing to obesity and associated metabolic disorders. The program highlights prevention strategies, lifestyle modifications, therapeutic interventions, public health initiatives, and emerging treatment options. Discussions will focus on sustainable weight management, bariatric interventions, and multidisciplinary approaches that reduce disease burden while improving metabolic health and overall patient well-being.

• Obesity Pathogenesis
• Metabolic Syndrome
• Weight Management Strategies
• Bariatric Interventions

Track 7: Endocrine Oncology

Endocrine Oncology highlights multidisciplinary approaches to the diagnosis, treatment, and management of endocrine cancers. Topics include thyroid malignancies, adrenal tumours, neuroendocrine tumours, molecular mechanisms, precision oncology, and targeted therapies. Participants will explore emerging research, innovative treatment strategies, and clinical advancements designed to improve survival rates, enhance quality of life, and support personalized cancer care.

• Thyroid Malignancies
• Adrenal Tumours
• Neuroendocrine Tumours
• Precision Oncology

Track 8: Bone and Mineral Metabolism

Bone and Mineral Metabolism examines the endocrine regulation of bone health, osteoporosis, calcium disorders, vitamin D metabolism, and metabolic bone diseases. Discussions will focus on prevention, early diagnosis, evidence-based treatment strategies, and innovative therapeutic developments. Participants will gain valuable insights into maintaining skeletal health, preventing fractures, and improving long-term outcomes through advances in endocrine and metabolic care.

• Osteoporosis
• Calcium Disorders
• Vitamin D Deficiency
• Metabolic Bone Diseases

Track 9: Diabetes Complications

Diabetes Complications focuses on the prevention, early detection, and comprehensive management of long-term complications associated with diabetes mellitus. Scientific discussions will cover both microvascular and macrovascular complications, including kidney, eye, nerve, and cardiovascular diseases. Participants will explore emerging therapeutic approaches, risk reduction strategies, and multidisciplinary interventions designed to reduce morbidity, improve quality of life, and enhance long-term patient outcomes.

• Diabetic Nephropathy
• Diabetic Retinopathy
• Diabetic Neuropathy
• Cardiovascular Complications

Track 10: Endocrine Nursing and Patient Care

Endocrine Nursing and Patient Care highlights the essential role of multidisciplinary teams in delivering high-quality endocrine healthcare. Topics include nursing practices, diabetes education, patient engagement, chronic disease management, and self-care strategies. Discussions will focus on improving treatment adherence, enhancing patient-centred care, and implementing innovative nursing approaches that support better clinical outcomes and long-term disease management.

• Diabetes Education
• Patient Engagement
• Chronic Disease Management
• Nursing Innovations

Track 11: Nutrition and Lifestyle Medicine

Nutrition and Lifestyle Medicine highlights the essential role of nutrition, physical activity, and behavioural modifications in preventing and managing endocrine and metabolic disorders. Evidence-based dietary interventions, exercise physiology, preventive healthcare, and sustainable lifestyle strategies will be discussed. Participants will gain practical insights into promoting healthier behaviours, improving metabolic outcomes, and supporting long-term patient wellness through comprehensive lifestyle interventions.

• Medical Nutrition Therapy
• Exercise Physiology
• Behavioural Interventions
• Preventive Healthcare

Track 12: Precision Medicine in Endocrinology

Precision Medicine in Endocrinology explores how genomic medicine, molecular diagnostics, biomarkers, and pharmacogenomics are transforming endocrine disease management. Discussions will focus on individualised therapies, risk prediction models, personalised treatment strategies, and advances in translational research. Participants will examine emerging opportunities that enhance clinical decision-making and improve patient outcomes through precision-based healthcare approaches.

• Genomic Medicine
• Biomarker Discovery
• Personalized Therapeutics
• Pharmacogenomics

Track 13: Endocrine Disorders in Women

Endocrine Disorders in Women addresses the unique hormonal and metabolic health challenges experienced throughout different stages of life. Topics include menopause, hormonal imbalances, pregnancy-related endocrine disorders, reproductive health, and metabolic complications. Scientific discussions will highlight diagnostic advances, innovative therapies, and evidence-based strategies aimed at improving women's endocrine health, quality of life, and long-term clinical outcomes.

• Menopause
• Hormonal Imbalances
• Pregnancy and Endocrine Disorders
• Women's Metabolic Health

Track 14: Endocrine Disorders in Men

Endocrine Disorders in Men focuses on hormonal conditions affecting male health, including testosterone deficiency, hypogonadism, infertility, metabolic disorders, and age-related endocrine changes. Participants will explore advances in diagnosis, treatment, hormone replacement therapies, and healthy ageing strategies. Discussions will emphasize comprehensive approaches that improve reproductive health, metabolic function, and overall quality of life.

• Androgen Disorders
• Male Infertility
• Hypogonadism
• Ageing and Hormonal Health

Track 15: Emerging Therapeutics and Drug Development

Emerging Therapeutics and Drug Development explores the latest innovations in pharmaceutical research, novel antidiabetic agents, hormone-based therapies, biologics, and targeted treatments for endocrine disorders. Discussions will review clinical trial outcomes, regulatory considerations, patient access, and future therapeutic directions. Participants will gain insights into cutting-edge drug development that supports safer, more effective, and personalised endocrine care.

• Novel Antidiabetic Agents
• Hormone-Based Therapies
• Biologics and Targeted Treatments
• Clinical Trials

Track 16: Digital Health and Tele-Endocrinology

Digital Health and Tele-Endocrinology examines how technology is transforming endocrine healthcare through telemedicine, remote patient monitoring, mobile health applications, and digital therapeutics. Discussions will focus on improving healthcare accessibility, patient engagement, and quality of care. Participants will explore innovative digital solutions and future advancements that support connected, efficient, and personalized endocrine disease management.

• Telemedicine Applications
• Remote Patient Monitoring
• Mobile Health Solutions
• Digital Therapeutics

Track 17: Endocrine Genetics and Molecular Biology

Endocrine Genetics and Molecular Biology explores how advances in genetics and molecular science are improving the understanding of endocrine disorders. Discussions will cover molecular pathways, inherited endocrine diseases, gene-based therapies, diagnostic innovations, and research breakthroughs. Participants will examine the growing role of genetics, epigenetics, and precision medicine in advancing disease diagnosis, treatment, and personalised endocrine healthcare.

• Genetic Endocrine Disorders
• Molecular Diagnostics
• Gene Therapy
• Epigenetics

Track 18: Treatment for Endocrinology

This track explores current and emerging therapeutic strategies for managing endocrine disorders. Sessions will cover pharmacological interventions, hormone replacement therapies, minimally invasive procedures, personalised treatment approaches, and advances in endocrine surgery. Participants will gain insights into evidence-based practices, novel drug development, and multidisciplinary care aimed at improving long-term outcomes for patients with hormonal and metabolic disorders.

• Hormone Replacement and Targeted Therapies
• Endocrine Surgery and Minimally Invasive Procedures
• Precision Medicine and Personalised Endocrine Care
• Emerging Drugs and Clinical Trials in Endocrinology

Track 19: Treatment for diabetes

This track focuses on innovative and evidence-based approaches to diabetes prevention, treatment, and long-term management. Discussions will include advancements in insulin therapy, oral and injectable medications, continuous glucose monitoring, artificial pancreas technologies, lifestyle interventions, and personalised diabetes care. The sessions aim to address current challenges while exploring future therapies that enhance glycaemic control, reduce complications, and improve the quality of life for people living with diabetes.

• Insulin Therapy and Glucose Monitoring Technologies
• Novel Antidiabetic Medications and Therapeutics
• Lifestyle Management, Nutrition, and Diabetes Prevention
• Personalised Diabetes Care and Digital Health Solutions

Track 20: Current Research and Innovations in Endocrinology and Diabetes

Current Research and Innovations in Endocrinology and Diabetes showcases groundbreaking discoveries, translational research, and emerging technologies across endocrine and metabolic sciences. Participants will explore novel disease mechanisms, innovative biomarkers, and breakthrough clinical studies while fostering collaboration between researchers and clinicians. Discussions will highlight future trends, scientific advancements, and transformative innovations shaping the future of endocrine and diabetes healthcare.

• Translational Research
• Novel Biomarkers
• Emerging Technologies
• Breakthrough Clinical Studies

Track 21: Future Trends and Challenges in Endocrinology

Future Trends and Challenges in Endocrinology explores emerging opportunities, evolving healthcare models, and innovative solutions shaping the future of endocrine medicine. Discussions will address healthcare delivery, workforce development, global collaborations, and strategies to manage the increasing burden of endocrine diseases. Participants will gain valuable insights into research priorities, policy development, and sustainable approaches for advancing clinical practice.

• Future Healthcare Models
• Innovation Strategies
• Workforce Development
• Global Collaborations

Track 22: Artificial Intelligence and Smart Technologies in Endocrinology and Diabetes

Artificial Intelligence and Smart Technologies in Endocrinology and Diabetes examines the transformative role of artificial intelligence in endocrine and diabetes care. Topics include AI-assisted diagnosis, predictive analytics, machine learning, clinical decision support systems, patient monitoring, and ethical considerations. Discussions will demonstrate how intelligent technologies and digital health solutions enhance diagnostic accuracy, personalised treatment, healthcare efficiency, and patient outcomes worldwide.

• AI-Assisted Diagnosis
• Predictive Analytics in Diabetes
• Machine Learning for Personalized Care
• Ethical and Regulatory Considerations of AI

Market Analysis

The global diabetes therapeutics and diagnostics market is experiencing significant growth, driven by the rising prevalence of diabetes, obesity, and other metabolic disorders worldwide. The market is projected to expand from $134.9 billion in 2025 to $241.5 billion by 2030, registering a strong CAGR of 12.4%. Increasing demand for advanced diagnostic technologies, continuous glucose monitoring systems, innovative drug therapies, and personalised treatment approaches is fuelling market expansion. Furthermore, growing investments in endocrinology research, digital health solutions, artificial intelligence, and precision medicine are creating new opportunities across the sector, positioning endocrine and metabolic healthcare as one of the fastest-growing areas of global medical innovation.

Global Diabetes Therapeutics and Diagnostics Market Overview

The global diabetes therapeutics and diagnostics market covers a wide range of products and services used in the management and monitoring of diabetes. It includes diabetes therapeutics such as injectable therapies (including GLP-1 and insulin) and oral antidiabetic drugs, diabetes monitoring devices like blood glucose meters, test strips, lancets, and continuous glucose monitoring systems, as well as insulin delivery devices such as pumps, pens, needles, and syringes. The market is also segmented by end users including hospitals and clinics, home care settings, and diagnostic centres, and it spans major regions such as North America, Europe, Asia-Pacific, the Middle East and Africa, and South America. Revenue trends are analyzed using 2024 as the base year, with estimates for 2025 and projections through 2030.

Visa Guidelines

Planning Your Trip to Rome, Italy? Join Endocrine Congress 2026

We are pleased to support international participants attending the 3rd International Congress on Endocrinology and Diabetes (Endocrine Congress 2026), scheduled for December 03–04, 2026 in Rome, Italy. To assist delegates with travel and visa procedures, the organizing committee provides official supporting documents to facilitate participation in the congress.

Official Supporting Documents Provided

• Official Letter of Invitation (Visa Support Letter)
• Official Abstract Acceptance Letter (for presenters)
• Payment Receipt / Confirmation Letter

Important Notes

The Official Invitation Letter will be issued only after successful registration and payment for the conference. Visa support documents are provided exclusively to registered participants and confirmed presenters of Endocrine Congress 2026.

How to Request Visa Support Letter

To request your official Invitation Letter, please contact the Program Manager, Mr. James Whitmore, via:

• Email: meevents@memeetings.com
• WhatsApp: +44 7735038467

When requesting, kindly include the following details:

• Full name (as per passport)
• Passport copy (showing passport number and date of birth)
• Abstract Acceptance Letter (for presenters, if applicable)
• Proof of registration/payment

Payment Methods

Registration fees can be completed via:

• Online Payment Gateway (Stripe)
• Bank Transfer

For any assistance regarding registration or payment, participants may contact the Program Manager using the details above. An official invoice can also be provided upon request for bank transfer processing.

We look forward to welcoming you to Endocrine Congress 2026 in Rome, Italy, for an engaging and impactful scientific experience.